Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07241299

Understanding Chronic Treatments by Patients Over 65 Years of Age

The ageing of the French population is accompanied by an increase in the number of chronic conditions per person. In 2008, according to IRDES (Institute for Research and Documentation in Health Economics), the average number of reported illnesses was six for people over the age of 65.

This multi-morbidity is associated with polypharmacy, which is a recognised risk factor for poor treatment compliance.

One of the causes of poor compliance is a lack of understanding of the treatment. In this context, the role of the general practitioner is central. General practitioners are responsible for more than three-quarters of medical prescriptions. They are the ones who initiate first-line treatments for chronic diseases, but also the ones who renew treatments introduced by specialists.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Gestonnairedu CURRS, Reims, Université de Reims Champagne-Ardenne, France

Loading trial locations.

About this study

Objectives Primary: To describe the understanding of chronic treatments by patients over 65 years of age.

Secondary: To investigate the factors associated with the understanding of chronic treatments by patients over 65 years of age.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Are aged 65 or over
  • Consulting one of the general practitioners agreeing to participate in the study
  • Have a prescription containing at least one chronic treatment (defined as a treatment lasting more than 3 months)
  • Agree to participate in the study.

Exclusion criteria

  • Does not understand French,
  • Has neurocognitive disorders
  • Lives in a medical facility
  • Consulting for an acute condition and whose prescription does not include chronic treatment.
  • Protected by law (guardianship, curatorship, judicial protection),

Treatment and study plan

Data Collection

Other

Data collection

Primary outcomes

  1. Understanding each chronic treatment listed on the prescription

    Time frame: Day 0

    A complete understanding of each chronic treatment, defined by knowledge of the dosage (number of doses and timing) and the indication for chronic treatment

Study contacts

Contact information is provided by the study sponsor or research team.

Gestonnairedu CURRS

CONTACT

[email protected]

0326918822 ext. 0033

Sponsors and collaborators

Lead sponsor

Université de Reims Champagne-Ardenne

Other

Registry information

Acronym: ordonnance

Important dates

Study start
2025
Primary completion
2025
Study completion
2026
First posted
Nov 21, 2025
Registry last updated
Nov 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.